Acute leukemia in pregnancy: a single institution experience with 23 patients

References

• Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279–287.
   PubMed Web of Science ®Google Scholar
• Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev. 2008;34:302–312.
   PubMed Web of Science ®Google Scholar
• Haas JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer. 1984;34:229–235.
   PubMed Web of Science ®Google Scholar
• Milojkovic D, Apperley JF. How I treat leukemia during pregnancy. Blood. 2014;123:974–984.
   PubMed Web of Science ®Google Scholar
• Greenlund LJ, Letendre L, Tefferi A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma. 2001;41:571–577.
   PubMed Web of Science ®Google Scholar
• Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer. 2005;104:110–117.
   PubMed Web of Science ®Google Scholar
• Brenner B, Avivi I, Lishner M. Haematological cancers in pregnancy. Lancet. 2012;379:580–587.
   PubMed Web of Science ®Google Scholar
• Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283–291.
   PubMed Web of Science ®Google Scholar
• Leslie KK, Koil C, Rayburn WF. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin N Am. 2005;32:627–640.
   PubMed Web of Science ®Google Scholar
• Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28:683–689.
   PubMed Web of Science ®Google Scholar
• Sanford B, Luger S, Devidas M, et al. Frontline-treatment of acute lymphoblastic leukemia (ALL) in older adolescents and young adults (AYA) using a pediatric regimen is feasible: toxicity results of the Prospective US Intergroup Trial C10403 (Alliance). Blood. 2013;122:3903–3903.
   Web of Science ®Google Scholar
• Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood. 1998;92:1556–1564.
   PubMed Web of Science ®Google Scholar
• Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol. 1989;16:388–396.
   PubMed Web of Science ®Google Scholar
• Reynoso EE, Shepherd FA, Messner HA, et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol. 1987;5:1098–1106.
   PubMed Web of Science ®Google Scholar
• Saleh AJ, Alhejazi A, Ahmed SO, et al. Leukemia during pregnancy: long term follow up of 32 cases from a single institution. Hematol Oncol Stem Cell Ther. 2014;7:63–68.
   PubMedGoogle Scholar
• Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173–177.
   PubMedGoogle Scholar
• Culligan DJ, Merriman L, Kell J, et al. The management of acute promyelocytic leukemia presenting during pregnancy. Clin Leukemia. 2007;1:183–191.
   Google Scholar
• Kawamura S, Yoshiike M, Shimoyama T, et al. Management of acute leukemia during pregnancy: from the results of a nationwide questionnaire survey and literature survey. Tohoku J Exp Med. 1994;174:167–175.
   PubMed Web of Science ®Google Scholar
• Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. N Engl J Med. 1987;317:1666–1667.
   PubMed Web of Science ®Google Scholar
• Amant F. Safety of chemotherapy in pregnancy. Clin Adv Hematol Oncol. 2012;10:258–259.
   PubMedGoogle Scholar
• Feliu J, Juarez S, Ordonez A, et al. Acute leukemia and pregnancy. Cancer. 1988;61:580–584.
   PubMed Web of Science ®Google Scholar
• Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128–1137.
   PubMed Web of Science ®Google Scholar
• Koren G. Fetal risks of maternal pharmacotherapy: identifying signals. Handb Exp Pharmacol. 2011;205:285–294.
   PubMedGoogle Scholar
• Aviles A, Neri N, Nambo MJ. Hematological malignancies and pregnancy: treat or no treat during first trimester. Int J Cancer. 2012;131:2678–2683.
   PubMed Web of Science ®Google Scholar
• Pereg D, Lishner M. Maternal and fetal effects of systemic therapy in the pregnant woman with cancer. Recent Results Cancer Res. 2008;178:21–38.
   PubMedGoogle Scholar
• Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313:837–841.
   PubMed Web of Science ®Google Scholar
• Yang D, Hladnik L. Treatment of acute promyelocytic leukemia during pregnancy. Pharmacotherapy. 2009;29:709–724.
   PubMed Web of Science ®Google Scholar
• Lynberg MC, Khoury MJ, Lammer EJ, et al. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance. Teratology. 1990;42:513–519.
   PubMedGoogle Scholar
• Consoli U, Figuera A, Milone G, et al. Acute promyelocytic leukemia during pregnancy: report of 3 cases. Int J Hematol. 2004;79:31–36.
   PubMed Web of Science ®Google Scholar
• Bawle EV, Conard JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology. 1998;57:51–55.
   PubMedGoogle Scholar
• Hyoun SC, Obican SG, Scialli AR. Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol. 2012;94:187–207.
   PubMed Web of Science ®Google Scholar
• Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008;22:247–259.
   PubMed Web of Science ®Google Scholar
• Carnevale A. [Contributions of a genetics department to the study of patients in a pediatric hospital]. Gac Med Mex. 1986;122:149–156.
   Google Scholar
• Dekrem J, Van Calsteren K, Amant F. Effects of fetal exposure to maternal chemotherapy. Paediatr Drugs. 2013;15:329–334.
   PubMed Web of Science ®Google Scholar
• Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010;33:221–228.
   PubMed Web of Science ®Google Scholar
• Abdel-Hady el S, Hemida RA, Gamal A, et al. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet. 2012;286:283–286.
   PubMed Web of Science ®Google Scholar
• Nulman I, Laslo D, Fried S, et al. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer. 2001;85:1611–1618.
   PubMed Web of Science ®Google Scholar
• Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015;373:1824–1834.
   PubMed Web of Science ®Google Scholar